Meeder Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-374
| Closed | -$4.41K | – | 895 |
|
|
2024
Q1 | $4.41K | Buy |
+374
| New | +$4.41K | ﹤0.01% | 647 |
|
|
2021
Q4 | – | Sell |
-1,400
| Closed | -$13K | – | 1593 |
|
|
2021
Q3 | $13K | Buy |
1,400
+1,331
| +1,929% | +$12.4K | ﹤0.01% | 1578 |
|
|
2021
Q2 | $1K | Sell |
69
-39
| -36% | -$565 | ﹤0.01% | 2336 |
|
|
2021
Q1 | $1K | Buy |
+108
| New | +$1K | ﹤0.01% | 2206 |
|
|
2020
Q4 | – | Sell |
-5,839
| Closed | -$83K | – | 1997 |
|
|
2020
Q3 | $83K | Sell |
5,839
-7,646
| -57% | -$109K | 0.01% | 832 |
|
|
2020
Q2 | $202K | Buy |
13,485
+11,627
| +626% | +$174K | 0.01% | 600 |
|
|
2020
Q1 | $17K | Buy |
+1,858
| New | +$17K | ﹤0.01% | 1305 |
|
|
2019
Q3 | – | Sell |
-5,852
| Closed | -$73K | – | 2178 |
|
|
2019
Q2 | $73K | Buy |
+5,852
| New | +$73K | 0.01% | 840 |
|
|
2017
Q4 | – | Sell |
-271
| Closed | -$4K | – | 1701 |
|
|
2017
Q3 | $4K | Buy |
+271
| New | +$4K | ﹤0.01% | 1318 |
|
|
2017
Q2 | – | Sell |
-1,313
| Closed | -$9K | – | 1722 |
|
|
2017
Q1 | $9K | Sell |
1,313
-3,553
| -73% | -$24.4K | ﹤0.01% | 871 |
|
|
2016
Q4 | $24K | Sell |
4,866
-675
| -12% | -$3.33K | ﹤0.01% | 629 |
|
|
2016
Q3 | $41K | Buy |
+5,541
| New | +$41K | ﹤0.01% | 656 |
|